eli lilly retatrutide trials clinical ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Eli Lilly retatrutide Phase 3 – Eli Lilly infiltrates anti-obesity market

US$ 21.24

★★★★★ 4.9 (19 reviews)

US$ 21.58

★★★★★ 4.4 (30 reviews)

US$ 21.17

★★★★★ 4.2 (14 reviews)

US$ 28.79

★★★★★ 4.1 (12 reviews)

US$ 26.29

★★★★★ 4.5 (9 reviews)

US$ 27.69

★★★★★ 4.2 (14 reviews)

US$ 22.41

★★★★★ 4.4 (25 reviews)

US$ 20.14

★★★★★ 4.7 (23 reviews)

US$ 28.43

★★★★★ 4.7 (19 reviews)

US$ 28.36

★★★★★ 4.3 (28 reviews)

US$ 22.58

★★★★★ 4.9 (10 reviews)

US$ 20.63

★★★★★ 4.4 (15 reviews)

US$ 23.62

★★★★★ 4.4 (24 reviews)

US$ 21.86

★★★★★ 4.7 (27 reviews)

US$ 27.25

★★★★★ 4.8 (22 reviews)

US$ 23.27

★★★★★ 5.0 (19 reviews)

US$ 29.57

★★★★★ 4.7 (25 reviews)

US$ 21.02

★★★★★ 4.9 (6 reviews)

US$ 27.91

★★★★★ 4.3 (29 reviews)

US$ 24.98

★★★★★ 4.4 (29 reviews)